Suppr超能文献

作为功能性亨德拉病毒受体的 Ephrin-B2 和 Ephrin-B3。

Ephrin-B2 and ephrin-B3 as functional henipavirus receptors.

机构信息

Structural Biology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

出版信息

Semin Cell Dev Biol. 2012 Feb;23(1):116-23. doi: 10.1016/j.semcdb.2011.12.005. Epub 2011 Dec 30.

Abstract

Members of the ephrin cell-surface protein family interact with the Eph receptors, the largest family of receptor tyrosine kinases, mediating bi-directional signaling during tumorogenesis and various developmental events. Surprisingly, ephrin-B2 and -B3 were recently identified as entry receptors for henipaviruses, emerging zoonotic paramyxoviruses responsible for repeated outbreaks in humans and animals in Australia, Southeast Asia, India and Bangladesh. Nipah virus (NiV) and Hendra virus (HeV) are the only two identified members in the henipavirus genus. While the initial human infection cases came from contact with infected pigs (NiV) or horses (HeV), in the more recent outbreaks of NiV both food-borne and human-to-human transmission were reported. These characteristics, together with high mortality and morbidity rates and lack of effective anti-viral therapies, make the henipaviruses a potential biological-agent threat. Viral entry is an important target for the development of anti-viral drugs. The entry of henipavirus is initiated by the attachment of the viral G envelope glycoprotein to the host cell receptors ephrin-B2 and/or -B3, followed by activation of the F fusion protein, which triggers fusion between the viral envelop and the host membrane. We review recent progress in the study of henipavirus entry, particularly the identification of ephrins as their entry receptors, and the structural characterization of the ephrin/Henipa-G interactions.

摘要

Ephrin 细胞表面蛋白家族的成员与 Eph 受体相互作用,Eph 受体是受体酪氨酸激酶家族中最大的家族,在肿瘤发生和各种发育事件中介导双向信号传递。令人惊讶的是,最近发现 Ephrin-B2 和 -B3 是亨尼帕病毒的进入受体,亨尼帕病毒是新兴的人畜共患病副粘病毒,导致澳大利亚、东南亚、印度和孟加拉国的人类和动物反复爆发。尼帕病毒(NiV)和亨德拉病毒(HeV)是亨尼帕病毒属中仅有的两种已确定的成员。虽然最初的人类感染病例来自接触受感染的猪(NiV)或马(HeV),但在最近的 NiV 爆发中,既有食源性传播,也有人与人之间的传播。这些特征,加上高死亡率和发病率以及缺乏有效的抗病毒治疗方法,使亨尼帕病毒成为一种潜在的生物制剂威胁。病毒进入是开发抗病毒药物的重要目标。亨尼帕病毒的进入是由病毒 G 包膜糖蛋白与宿主细胞受体 Ephrin-B2 和/或 -B3 的附着起始的,随后激活 F 融合蛋白,触发病毒包膜与宿主膜之间的融合。我们综述了亨尼帕病毒进入研究的最新进展,特别是 Ephrins 作为其进入受体的鉴定,以及 Ephrin/Henipa-G 相互作用的结构特征。

相似文献

1
Ephrin-B2 and ephrin-B3 as functional henipavirus receptors.作为功能性亨德拉病毒受体的 Ephrin-B2 和 Ephrin-B3。
Semin Cell Dev Biol. 2012 Feb;23(1):116-23. doi: 10.1016/j.semcdb.2011.12.005. Epub 2011 Dec 30.
10
Henipavirus membrane fusion and viral entry.亨尼帕病毒的膜融合与病毒进入。
Curr Top Microbiol Immunol. 2012;359:79-94. doi: 10.1007/82_2012_200.

引用本文的文献

2
Nipah virus: pathogenesis, genome, diagnosis, and treatment.尼帕病毒:发病机制、基因组、诊断与治疗
Appl Microbiol Biotechnol. 2025 Jul 1;109(1):158. doi: 10.1007/s00253-025-13474-6.
5
Human Riboviruses: A Comprehensive Study.人类核糖病毒:一项全面研究。
J Mol Evol. 2025 Feb;93(1):11-37. doi: 10.1007/s00239-024-10221-9. Epub 2024 Dec 31.

本文引用的文献

2
Entry and fusion of emerging paramyxoviruses.新兴副粘病毒的进入与融合
PLoS Pathog. 2010 Jun 24;6(6):e1000881. doi: 10.1371/journal.ppat.1000881.
6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验